Germany - Healthcare, Regulatory and Reimbursement Landscape

Report
172 Pages
June 2021
Region: Germany
GlobalData
ID: 2588295

The publisher, an industry analysis specialist, has released its latest report, "Germany - Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The German pharmaceutical market is the largest by value and second largest by volume in Europe. Globally, it is the fourth largest market by value after the US, China, and Japan. The market value, in terms of Euros, increased from €42.1B in 2013 to an estimated €62.4B in 2020 at a Compound Annual Growth Rate (CAGR) of 5.8%. In terms of US dollars, the market increased from $56B in 2013 to an estimated $71.3B in 2020 at a CAGR of 3.7%. The medical devices market of Germany was $21.6B in 2017, which increased at a CAGR of 3% to reach $23.5B in 2020. The market is expected to grow at a CAGR of 4.7% from $26.6B in 2021 to reach $29.6B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck KGaA, and Pfizer.
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the German healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving the German healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the German healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights - Facts about the German Healthcare Market
2.3 Key Highlights: Healthcare Startups in Germany
2.4 Key Events: German Healthcare Industry, 2015-2021
2.5 Key Events: German Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Germany, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Impact of Brexit on the German Health Sector
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Market - Supply Channels, Germany
3.6 Pharmaceutical Market - Market Segments
3.7 Major Therapeutic Areas, Germany
3.8 COVID-19 Epidemiology, Germany
3.9 COVID-19 Impact and Developments, Germany
3.10 COVID-19 Impact and Developments in the Healthcare Market, Germany
3.11 COVID-19 Clinical Trials Landscape, Germany
3.12 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Germany, 2020-2021
6.2 Deal Analysis: Medical Device Market, Germany, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Germany
7.2 HealthTech Deals Landscape, Germany
7.3 Key HealthTech Deals, Germany
7.4 Adoption of Technology in Healthcare, Germany
7.5 Digital Health Regulations, Germany
7.6 Digital Health: Benefits and Risks, Germany

8. Market Access

8.1 Overview of Healthcare System, Germany
8.2 Reimbursement Process, Germany
8.3 Overview of Insurance Providers, Germany
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Germany
8.5 Pricing Policies, Germany
8.6 Regulatory Landscape, Germany
8.6.1 Overview of Regulatory Agencies, Germany
8.6.2 Marketing Authorization for Pharmaceutical Products, EU
8.6.3 Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Germany
8.6.4 Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Germany
8.6.5 Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Germany
8.6.6 Marketing Authorization for Pharmaceutical Products, National Procedure, Germany
8.6.7 Marketing Authorization for Generic Drugs, Germany
8.6.8 Marketing Authorization for Biosimilars, Germany
8.6.9 Marketing Authorization for Medical Devices, Germany
8.6.10 Exports and Imports, Germany
8.6.11 Intellectual Property Rights, Patent, Germany
8.6.12 Intellectual Property Rights, Trademark, Germany
8.6.13 Clinical Trial Regulations, Germany
8.6.14 Pharmaceutical Clinical Trials Landscape, Germany
8.6.15 Medical Devices Clinical Trials Landscape, Germany
8.6.16 Pharmacy License Regulations, Germany
8.6.17 Online Pharmacy Regulations, Germany
8.6.18 Pharmaceutical Advertising Regulations, Germany
8.6.19 Labeling and Packaging Regulations, Germany

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Germany
9.2 Healthcare Facilities, Germany
9.3 Healthcare Parameters, Germany
9.4 Life Expectancy and Immunization Rate, Germany
9.5 Environmental Health, Germany
9.6 Healthcare Personnel, Germany
9.7 Disease Burden, Germany
9.8 Healthcare Expenditure, Germany
9.9 Healthcare Spending Components and Pharmaceutical Spending, Germany

10. Trade Associations, Germany11. Trade Fairs, Germany12. Opportunities and Challenges

13. Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables

Table 1: Biotechnology Companies General Data, Germany, 2018-2019
Table 2: Biosimilars approved in 2021, Germany, 2021
Table 3: COVID-19 Indicators (Number of cases), Germany and Global, 2020-2021
Table 4: COVID-19 Vaccines, Germany, 2020-2021
Table 5: Medical Devices Market, Germany, Major Segments ($B), 2020
Table 6: General Surgery Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 7: Cardiovascular Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 8: Healthcare IT Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 9: Orthopedic Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: In Vitro Diagnostics Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: New Drug Application Information, Germany, 2021
Table 12: Patent Fees, Germany, 2020
Table 13: Trademark Fees, Germany, 2020
Table 14: Clinical Trial Fees, Germany, 2020
Table 15: Label of a Pharmaceutical Product, Germany, 2020
Table 16: Label of Radiopharmaceutical Product, Germany, 2020
Table 17: Labeling of Small Packages, Germany, 2020
Table 18: Labeling and Packaging Leaflet, Germany, 2020
Table 19: Conferences and Trade Fairs, Germany, 2021

List of Figures

Figure 1: Pharmaceutical Market, Germany, Revenue ($B and €B), 2013-2020
Figure 2: Medical Devices Market, Germany, Revenue ($B), 2017-2022
Figure 3: Healthcare Startups in Germany, 2020
Figure 4: Country Profile, Germany, 2020
Figure 5: Pharmaceutical Market, Germany, Revenue ($B), 2012-2019
Figure 6: Pharmaceutical Market, Germany, Revenue Forecast ($B), 2020-2025
Figure 7: Pharmaceutical Exports ($B), Germany, 2012-2020
Figure 8: Top Export Partners, Germany, 2020
Figure 9: Pharmaceutical Imports ($B), Germany, 2012-2020
Figure 10: Top Import Partners, Germany, 2020
Figure 11: Generic Drugs (Market share % by value and volume), Germany, 2010-2018
Figure 12: Generic Drug Marketing Authorization Applications (Number), EU, 2015-2021
Figure 13: Biotechnology SME Share (%), Germany, 2020
Figure 14: OTC Medicines Market, Revenue ($B), Germany, 2013-2020
Figure 15: OTC Medicines Market, Major Categories ($M), Germany, 2020
Figure 16: OTC Medicines Market, Major Distribution Channels ($M), Germany, 2017
Figure 17: Pharmaceutical Sales by Drug Category ($B), Germany, 2019
Figure 18: Major Therapeutic Areas by Pharmaceutical Consumption (DDD per million inhabitants), Germany, 2016-2018
Figure 19: COVID-19 (Number of cases), Germany, 2020-2021
Figure 20: COVID-19 (Number of deaths), Germany, 2020-2021
Figure 21: COVID-19 Risk Areas Classification, Germany, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Timeline, Germany, 2020-2021
Figure 23: COVID-19 Vaccination Priority Groups, Germany, 2020-2021
Figure 24: COVID-19 Vaccine Administration, Number of People, Germany, 2020-2021
Figure 25: Top COVID-19 Marketed Products by Category (Number of available marketed products), Germany, 2020-2021
Figure 26: Top COVID-19 IVD Products by Equipment Type (Number of available marketed products), Germany, 2020-2021
Figure 27: Top COVID-19 Marketed Products by Product Class (Number of available marketed products), Germany, 2020-2021
Figure 28: Top COVID-19 Anesthesia and Respiratory Devices Products by Equipment Type (Number of available marketed products), Germany, 2020-2021
Figure 29: COVID-19 Clinical Trials Count by Phase, Germany, 2020-2021
Figure 30: COVID-19 Clinical Trials Count by Trial Status, Germany, 2020-2021
Figure 31: Top Five COVID-19 Clinical Trials Sponsors by Count, Germany, 2020-2021
Figure 32: Pharmaceutical Market, Major Players, 2020
Figure 33: Medical Devices Market, Germany, Revenue ($B), 2015-2020
Figure 34: Medical Devices Market, Germany, Revenue Forecast ($B), 2021-2025
Figure 35: Medical Devices Market, Germany, Major Segments (%), 2020
Figure 36: General Surgery Devices Market, Germany, Revenue ($B), 2017-2025
Figure 37: General Surgery Devices Market, Germany, Market Share of Major Players (%), 2020
Figure 38: Cardiovascular Devices Market, Germany, Revenue ($B), 2017-2025
Figure 39: Cardiovascular Devices Market, Germany, Market Share of Major Players (%), 2020
Figure 40: Healthcare IT Market, Germany, Revenue ($B), 2017-2025
Figure 41: Healthcare IT Market, Germany, Market Share of Major Players (%), 2018
Figure 42: Orthopedic Devices Market, Germany, Revenue ($B), 2017-2025
Figure 43: Orthopedic Devices Market, Germany, Market Share of Major Players (%), 2020
Figure 44: In Vitro Diagnostics Market, Germany, Revenue ($B), 2017-2025
Figure 45: In Vitro Diagnostics Market, Germany, Market Share of Major Players (%), 2020
Figure 46: Diagnostic Market, Germany, Revenue ($B), 2015-2020
Figure 47: Diagnostic Market, Germany, Revenue ($B), 2021-2025
Figure 48: Medical Devices Market, Germany, Revenue ($B) of Major Companies, 2020
Figure 49: Deal Value and Deal Count, Pharmaceutical Market, Germany, 2020-2021
Figure 50: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Germany, 2020-2021
Figure 51: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Germany, 2020-2021
Figure 52: Top Therapy Areas by Deal Value, Pharmaceutical Market, Germany, 2020-2021
Figure 53: Top Therapy Areas by Deal Count, Pharmaceutical Market, Germany, 2020-2021
Figure 54: M&A Deals by Quarter, Pharmaceutical Market, Germany, 2020-2021 (by value and by number)
Figure 55: VC Deals by Quarter, Pharmaceutical Market, Germany, 2020-2021 (by value and by number)
Figure 56: Deal Value and Deal Count, Medical Devices Market, Germany, 2020-2021
Figure 57: Deal Value and Deal Count, Quarterly, Medical Devices Market, Germany, 2020-2021

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1936EUR$1,995USD£1,669GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3872EUR$3,990USD£3,339GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5807EUR$5,985USD£5,008GBP

Table of Contents

Related Topics

Related Reports

Global Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) - Forecast to 2028

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

Global Disease Management Apps Market Size, Share & Industry Trends Analysis Report By Indication (Obesity, Mental Health, Cardiovascular Issues, Diabetes and Others), By Device, By Platform Type, By Regional Outlook and Forecast, 2023-2029

Europe Disease Management Apps Market Size, Share & Industry Trends Analysis Report By Indication (Obesity, Mental Health, Cardiovascular Issues, Diabetes and Others), By Device, By Platform Type, By Country and Growth Forecast, 2023-2029

Healthcare Reimbursement Global Market Report 2024